Laboratory Technician - #142694

Job Description

We want you to feel inspired every day. We’re future-focused and our business is growing. We succeed together through passion, commitment, and teamwork, and so can you.

We are currently recruiting for a Laboratory Technician to join the Laboratory Management Team (LMT) team.

The purpose of the role is to carry out routine tasks to aid and support the smooth running of the day-to-day activities of the non -GXP laboratory including waste management, stock control, reagent prep and cleans.

Your Responsibilities In This Role Would Be

• Overseeing, maintaining and ensuring quality of key stock consumables, media, solutions, buffers used by Scientists to ensure work activities are maintained
• Cleaning and maintaining the laboratory equipment and facilities according to schedule
• Ensuring OXB laboratory waste management systems are adhered to (inc. autoclave use and waste out)
• Making sure equipment is serviced and calibrated and fit for purpose. Raising new asset request numbers / preparing asset relocation and disposing of forms for laboratory equipment, chaperone engineers
• Keeping documentation maintained, populated, QC checked and appropriately filed in accordance with local rules
• Assisting in maintaining the health and safety compliance as applicable
  
  

We Are Looking For

• Educated to a minimum of GCSE level (in a science subject) or equivalent qualification level or skills gained within a similar work place and position
• Degree in a scientific subject (preferred)
• Previous aseptic technique experience (preferred)
• Experience in working in laboratory
• Computer skills essential with a strong knowledge of Microsoft Office
• Please note that eligibility for internal opportunities—such as roles in Process Development, Analytical Development, or Quality Control—requires meeting minimum tenure requirements in your current position
  
  

About Us

OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.

What’s In It For You

• Highly competitive total reward packages
• Wellbeing programmes
• Development opportunities
• Welcoming, friendly, supportive colleagues
• A diverse and inclusive working environment
• Our values are: Responsible, Responsive, Resilient, Respect
• State of the art laboratory and manufacturing facilities
  
  

We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you.

Collaborate. Contribute. Change lives

We Offer

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.